These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 15058160
1. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors]. Markocka-Maczka K. Wiad Lek; 2003; 56(11-12):537-40. PubMed ID: 15058160 [Abstract] [Full Text] [Related]
2. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma. Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259 [Abstract] [Full Text] [Related]
3. The role of different tumor markers in the early diagnosis and prognosis of pancreatic carcinoma and chronic pancreatitis. Hámori J, Arkosy P, Lenkey A, Sápy P. Acta Chir Hung; 1997 May; 36(1-4):125-7. PubMed ID: 9408313 [Abstract] [Full Text] [Related]
4. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9. Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777 [Abstract] [Full Text] [Related]
5. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Ozkan H, Kaya M, Cengiz A. Hepatogastroenterology; 2003 Jun; 50(53):1669-74. PubMed ID: 14571813 [Abstract] [Full Text] [Related]
6. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. Sperti C, Pasquali C, Guolo P, Polverosi R, Liessi G, Pedrazzoli S. Cancer; 1996 Jul 15; 78(2):237-43. PubMed ID: 8673998 [Abstract] [Full Text] [Related]
7. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma]. Nouts A, Lévy P, Voitot H, Bernades P. Gastroenterol Clin Biol; 1998 Feb 15; 22(2):152-9. PubMed ID: 9762189 [Abstract] [Full Text] [Related]
11. The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma. Nazli O, Bozdag AD, Tansug T, Kir R, Kaymak E. Hepatogastroenterology; 2000 Feb 15; 47(36):1750-2. PubMed ID: 11149048 [Abstract] [Full Text] [Related]
13. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer]. Clavé P, Boadas J, González-Carro P, Mora J, Pérez C, Martínez A, Roca M, Lluís F, Farré A. Gastroenterol Hepatol; 1999 Feb 15; 22(7):335-41. PubMed ID: 10535205 [Abstract] [Full Text] [Related]
14. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer]. Dai MH, Zhao YP, Cai LX, Zhu Y. Zhonghua Wai Ke Za Zhi; 2003 May 15; 41(5):332-5. PubMed ID: 12892584 [Abstract] [Full Text] [Related]
16. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Liao WC, Wu MS, Wang HP, Tien YW, Lin JT. Pancreas; 2009 May 15; 38(4):422-6. PubMed ID: 19214136 [Abstract] [Full Text] [Related]